The global Inhaled Nitric Oxide Market is witnessing significant growth, driven by the increasing prevalence of respiratory disorders, rising neonatal care requirements, and advancements in critical care therapeutics. Inhaled nitric oxide (iNO) plays a vital role in improving oxygenation and reducing pulmonary hypertension, particularly in neonatal and critical care settings.

Market Size and Growth

The global inhaled nitric oxide market size was valued at USD 954.07 million in 2024. It is expected to reach from USD 1,034.21 million by 2025 to USD 1,547.95 million by 2033, growing at a CAGR of 8.4% during the forecast period (2025–2033).

Unlock Full Report Insights and Strategic Analysis- https://straitsresearch.com/report/inhaled-nitric-oxide-market

Key Highlights

• Largest Region: North America dominates the market due to advanced healthcare infrastructure and high adoption of neonatal care technologies.

• Fastest Growing Region: Asia-Pacific is expected to grow at the fastest CAGR of 8.9%, driven by improving healthcare facilities and increasing awareness of respiratory treatments.

• Largest Segment: Neonatal hypoxic respiratory failure (HRF) segment holds the largest share due to high incidence in newborns requiring immediate treatment.

• Fastest Growing Segment: Acute respiratory distress syndrome (ARDS) segment is anticipated to grow at a significant CAGR owing to rising critical care cases globally.

Market Dynamics

Drivers
The inhaled nitric oxide market is primarily driven by the increasing incidence of respiratory disorders such as neonatal hypoxic respiratory failure and acute respiratory distress syndrome. The growing demand for advanced neonatal care, particularly in premature infants, is significantly boosting the adoption of iNO therapy. Additionally, technological advancements in delivery systems and increasing investments in healthcare infrastructure are further supporting market growth.

Restraints and Opportunities
Despite strong growth potential, the market faces challenges such as the high cost of therapy and limited accessibility in developing regions. Regulatory complexities and the need for specialized equipment can also hinder market expansion. However, these challenges are paving the way for innovations in cost-effective delivery systems and portable nitric oxide devices. Expanding healthcare access in emerging economies and ongoing research into new therapeutic applications present lucrative opportunities for market players.

Top Market Players List

• Mallinckrodt Pharmaceuticals

• Linde plc

• Air Liquide

• Praxair Inc.

• Vero Biotech LLC

• Bellerophon Therapeutics

• Messer Group GmbH

• SOL Group

• Novoteris LLC

• Beyond Air Inc.

Download the Free Sample Report - https://straitsresearch.com/report/inhaled-nitric-oxide-market/request-sample

Market Segmentation

By Application

• Neonatal Hypoxic Respiratory Failure (HRF)

• Acute Respiratory Distress Syndrome (ARDS)

• Others

By Age Group

• Neonates

• Adults

By End-User

• Hospitals

• Ambulatory Surgical Centers

• Others

By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East & Africa

About Us

Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

Contact Us

Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)